Sorry don't mean to be 'that' guy but your numbers are off.
It doesn't state anywhere that this revenue is per month, just that it's per patient (could be a yearly aggregate amount).
So, 3925 patients in July, using worst case scenario of $175US/year per patient =
~$57,000 in July.
The entire 2019 saw 27,496 patients, assuming the worst case scenario like above:
2019 = $4.8M Revenue.
If they are expecting CY2020 to have triple the patients:
CY2020 = Approx. $14M Revenue annualised.
It's not bad, they have a lot of costs associated with running the business, but it does show exponential growth & scalability which is whats important.
Will take a lot more money + time to become profitable however you can also see the huge potential that exists here. Current MC of around $34M is about right, to list on the NASDAQ they will need a much higher market cap however, so I'm interested to see how they will manage to do that.
The story here is on trend, let's see what happens.
Ann: Ten US university hospitals now deploying IDTF platform, page-9
Add to My Watchlist
What is My Watchlist?